| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
233,846 |
213,565 |
$12.69M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
80,843 |
73,857 |
$3.98M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
36,202 |
32,902 |
$2.92M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
32,861 |
30,445 |
$2.86M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
19,924 |
18,526 |
$1.71M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,678 |
16,909 |
$1.49M |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
21,049 |
19,430 |
$610K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
6,434 |
5,796 |
$603K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
45,770 |
42,306 |
$595K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
8,240 |
7,559 |
$595K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
8,502 |
7,817 |
$394K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
26,130 |
12,082 |
$343K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
17,616 |
16,408 |
$261K |
| 92551 |
|
22,841 |
20,948 |
$203K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,973 |
4,595 |
$169K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
9,170 |
8,628 |
$158K |
| 99173 |
|
26,322 |
24,225 |
$143K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,897 |
3,547 |
$127K |
| 96160 |
|
8,290 |
7,553 |
$94K |
| 96127 |
|
13,627 |
12,108 |
$63K |
| 3008F |
|
68,510 |
62,896 |
$62K |
| 87428 |
|
977 |
931 |
$57K |
| 90670 |
|
19,174 |
17,765 |
$48K |
| 36416 |
|
27,080 |
23,996 |
$38K |
| 83655 |
|
2,131 |
1,939 |
$26K |
| 90686 |
|
31,354 |
28,793 |
$21K |
| 90651 |
|
1,468 |
1,311 |
$21K |
| 90677 |
|
3,518 |
3,007 |
$20K |
| 92583 |
|
455 |
428 |
$16K |
| 85018 |
|
5,864 |
5,224 |
$15K |
| 99174 |
|
1,546 |
1,413 |
$15K |
| D1206 |
Topical application of fluoride varnish |
732 |
722 |
$13K |
| 90723 |
|
13,169 |
12,125 |
$12K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
136 |
121 |
$8K |
| D0190 |
|
732 |
722 |
$8K |
| 90680 |
|
9,647 |
8,891 |
$8K |
| 99460 |
|
115 |
102 |
$8K |
| 54150 |
|
41 |
37 |
$6K |
| 80061 |
Lipid panel |
398 |
349 |
$6K |
| 96161 |
|
10,306 |
9,486 |
$6K |
| 0072A |
|
143 |
120 |
$5K |
| 87807 |
|
508 |
456 |
$5K |
| 0071A |
|
132 |
99 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
251 |
226 |
$4K |
| 90647 |
|
11,888 |
10,980 |
$4K |
| 92552 |
|
192 |
182 |
$4K |
| 90734 |
|
626 |
546 |
$3K |
| 87634 |
|
59 |
55 |
$3K |
| 90633 |
|
4,285 |
3,927 |
$3K |
| 90674 |
|
2,561 |
2,432 |
$2K |
| 90661 |
|
2,776 |
2,377 |
$2K |
| 99381 |
|
30 |
24 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
239 |
216 |
$2K |
| 96380 |
|
93 |
67 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
106 |
81 |
$2K |
| 90707 |
|
801 |
700 |
$1K |
| 90716 |
|
630 |
565 |
$1K |
| 0001A |
|
24 |
24 |
$944.00 |
| 0081A |
|
27 |
12 |
$884.14 |
| 69210 |
|
14 |
12 |
$573.49 |
| 90710 |
|
156 |
143 |
$570.12 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
341 |
313 |
$456.76 |
| 36415 |
Collection of venous blood by venipuncture |
167 |
158 |
$364.02 |
| 90696 |
|
110 |
98 |
$275.33 |
| 96381 |
|
12 |
12 |
$250.83 |
| 81003 |
|
101 |
96 |
$232.55 |
| 90715 |
|
139 |
126 |
$229.57 |
| 82948 |
|
77 |
70 |
$164.41 |
| 90685 |
|
1,562 |
1,447 |
$94.78 |
| 88720 |
|
12 |
12 |
$47.30 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
250 |
225 |
$44.10 |
| 90688 |
|
625 |
588 |
$20.85 |
| 90700 |
|
53 |
52 |
$2.80 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
12 |
12 |
$0.90 |
| 90656 |
|
518 |
483 |
$0.22 |
| 90381 |
|
28 |
25 |
$0.06 |
| 91300 |
|
284 |
269 |
$0.00 |
| 91308 |
|
33 |
15 |
$0.00 |
| 90672 |
|
14 |
12 |
$0.00 |
| 91307 |
|
550 |
439 |
$0.00 |